Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
38 minutes ago • Google News
Collegium Pharmaceutical Inc (COLL)
US$ 33.18-1.81%
Price Chart
Key Statistics
Market Cap
$ 958.8M
P/E Ratio
24.45
Revenue (TTM)
$ 664.28M
Volume
318.39K
52W High
$ 42.29
52W Low
$ 23.23
Dividend Yield
0.00%
Beta
0.63
Technicals
50-Day MA
28.3379
200-Day MA
32.2045
52 Week High
42.2873
52 Week Low
23.23
About COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
Employees
357
Headquarters
Stoughton, MA
CEO
Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg